There are two comments on this story. Click here to view comments >>

Get stories like this in a free daily email

June 27, 2012 in Health
(AP Photo/Food and Drug Administration) photo

This photo provided by Food and Drug Administration shows Arena Pharmaceutical’s anti-obesity pill Belviq. The Food and Drug Administration has approved Belviq, the first new prescription drug for long-term weight loss to enter the U.S. market in over a decade. The agency cleared the pill Wednesday for adults who are obese or are overweight with at least one medical complication, such as diabetes or high cholesterol.